Nanodisc - Page 13 of 36 - DIMA Biotechnology

Select Expression Host

E.coli
(0)
E.coli expression system
(0)
HEK293
(716)

Select Conjugate

PE Conjugate
(0)
Unconjugated
(1)
Biotinylated
(0)
PE-conjugated
(0)

Full Length Transmembrane Proteins

Human TPC1 full length protein-synthetic nanodisc

SKU: FLP100605 Target: TPC1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human CTSR4 full length protein-synthetic nanodisc

SKU: FLP100604 Target: CTSR4

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human CTSR3 full length protein-synthetic nanodisc

SKU: FLP100603 Target: CTSR3

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human CTSR2 full length protein-synthetic nanodisc

SKU: FLP100602 Target: CTSR2

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human CTSR1 full length protein-synthetic nanodisc

SKU: FLP100601 Target: CTSR1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human MBP-CLDN6 full length protein-synthetic nanodisc

SKU: FLP110008 Target: CLDN6

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human MBP-AGTR1 full length protein-synthetic nanodisc

SKU: FLP110098 Target: AGTR1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human TRPV6 full length protein-synthetic nanodisc

SKU: FLP100159 Target: TRPV6

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human AQP5 full length protein-synthetic nanodisc

SKU: FLP100158 Target: AQP5

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human ADRB1 full length protein-synthetic nanodisc

SKU: FLP100157 Target: ADRB1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human ABCG1 full length protein-synthetic nanodisc

SKU: FLP100156 Target: ABCG1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human TAS1R2 full length protein-synthetic nanodisc

SKU: FLP100155 Target: TAS1R2

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human VN1R1 full length protein-synthetic nanodisc

SKU: FLP100495 Target: VN1R1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human VIPR2 full length protein-synthetic nanodisc

SKU: FLP100494 Target: VIPR2

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human VIPR1 full length protein-synthetic nanodisc

SKU: FLP100493 Target: VIPR1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human V1BR full length protein-synthetic nanodisc

SKU: FLP100491 Target: V1BR

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human V2R full length protein-synthetic nanodisc

SKU: FLP100492 Target: V2R

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human V1AR full length protein-synthetic nanodisc

SKU: FLP100490 Target: V1AR

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human TS1R1 full length protein-synthetic nanodisc

SKU: FLP100489 Target: TS1R1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human TRFR full length protein-synthetic nanodisc

SKU: FLP100488 Target: TRFR

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Posts found

The structure of MSP-Nanodisc (left) and Synthetic Nanodisc (right)

Synthetic Nanodisc, A Promising Solution for “Undruggable” Membrane Proteins

[...]

26
Jul

The glucagon receptor (GCGR)：A Key Target in Glucose Metabolism

On June 25, 2024, at the 2024 American Diabetes Association (ADA) Scientific Sessions, Suzhou Innovent Biologics [...]

29
Aug

GLP1R Target: Not Just for Blood Sugar Control and Weight Loss, but a Potential Breakthrough for Anti-Nausea in Weight Loss Medications

Currently, the most popular GLP1-based monotherapy, Semaglutide, controls blood sugar by promoting insulin secretion and [...]

19
Aug

GIP Receptor (GIPR): A Novel Target for Glycemic Control and Weight Loss

On February 27, 2024, Viking Therapeutics announced the results of their Phase IIa clinical study [...]

08
Aug

Discover DIMA at Membrane Protein Paris 2024

2024-07-26

Membrane proteins are essential for cell functions such as maintaining cellular physiological processes, playing crucial [...]

STEAP1 – A Therapeutic Target for Prostate Cancer

At the 2024 ASCO Annual Meeting, HANGZHOU DAC BIOTECHNOLOGY (abbreviated as DAC Biotech) presented preclinical [...]

03
Jul

The structure of Claudin proteins enables the Claudins tight protein family to effectively maintain the polarity of epithelial and endothelial cells.

Tumor Immune Target – Claudin18.2

Since Ganymed unveiled the efficacy data of Zolbetuximab (IMAB362), the anti-Claudin18.2 monoclonal antibody, for the [...]

18
Apr

ActRII – A Novel Drug Target that Preserves Skeletal Muscle Mass and Enhances Fat Loss

In the previous article, we focused on the popular drug target for weight loss, G [...]

10
Apr

20-HETE Receptor (GPR75) Signaling in Endothelial Cells

GPR75 – An Emerging Target for Weight Loss Drugs

When it comes to weight loss medications, one cannot overlook the remarkable success of Semaglutide [...]

01
Apr

Proposed role of HSD17B13 in modulating disease progression in NAFLD

HSD17B13-NASH Therapeutic Emerging Target

On November 30, 2023, Inipharm, a pharmaceutical company focused on severe liver diseases, announced the [...]

19
Feb

Pages found

Mammalian Cell Protein Production Platform

revolutionizing-drug-development-synthetic-nanodiscs

Synthetic Nanodisc

Case Study on Membrane Protein

Product case studies

DiMPro^TM Full Length Transmembrane Proteins

FAQ

Company Introduction

Company News

Posts found

Synthetic Nanodisc, A Promising Solution for “Undruggable” Membrane Proteins

The glucagon receptor (GCGR)：A Key Target in Glucose Metabolism

GLP1R Target: Not Just for Blood Sugar Control and Weight Loss, but a Potential Breakthrough for Anti-Nausea in Weight Loss Medications

GIP Receptor (GIPR): A Novel Target for Glycemic Control and Weight Loss

Discover DIMA at Membrane Protein Paris 2024

STEAP1 – A Therapeutic Target for Prostate Cancer

Tumor Immune Target – Claudin18.2

ActRII – A Novel Drug Target that Preserves Skeletal Muscle Mass and Enhances Fat Loss

GPR75 – An Emerging Target for Weight Loss Drugs

HSD17B13-NASH Therapeutic Emerging Target

Pages found

Login